Michael L Eisenberg, MD

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

16 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Eisenberg’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

16 of 16 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health BreathEasy (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Clarity (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Harmony (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Honor+ Plan (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health My Choice CalCare (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Silicon (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health smartHMO (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health the ONE (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
SCAN Balance (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Classic (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN MyChoice (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Strive (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026

California Medical Board record

Licence A93272 · Current

Licensed to practise in California · since 2005 · expires 2027-07-31 · Yale University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Original Medicare doctor bills

$44,363

Medicare paid this office $44,363 for 243 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Sort by

Largest Original Medicare bills

New patient visit (45+ min)	63	$6,291	$100
Return visit (30+ min)	71	$5,827	$81
Short return visit (20+ min)	56	$4,598	$50
Return visit (30+ min)	20	$2,317	$116
Placement of hormone pellet under skin	19	$2,148	$41

See all 6 services

Sort by

Every Original Medicare service billed

New patient visit (45+ min)	63	$6,291	$100
Return visit (30+ min)	71	$5,827	$81
Short return visit (20+ min)	56	$4,598	$50
Return visit (30+ min)	20	$2,317	$116
Placement of hormone pellet under skin	19	$2,148	$41
Short return visit (20+ min)	13	$996	$71

Procedures Medicare counted

Sort by

Procedure volume Medicare published

Melanoma (skin cancer) excision	1-10	None

Who their Medicare patients are

243 Original Medicare patients in 2024. Average age 71 · Under 65 10% · 85 and older 5% · Also on Medicaid 16% · Health risk score 1.35. At or below the middle of the specialty; the typical urology clinician is at 1.36.

Conditions among them: High blood pressure 63% · Coronary heart disease 35% · Diabetes 30% · Cancer 28% · Chronic kidney disease 19% · Atrial fibrillation 19% · Depression 16% · Heart failure 12% · Stroke 10% · COPD 9% · Dementia 5%.

The office billed $296,978, Medicare allowed $60,904 and paid $44,363; for 417 services of 28 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Sort by

Original Medicare by year

2024	243	417	71	1.35	$296,978	$44,363
2023	239	401	71	1.25	$279,665	$43,137
2022	242	398	71	1.26	$257,451	$38,635
2021	215	397	70	1.17	$341,079	$43,451
2020	227	363	69	1.36	$292,374	$37,638
2019	253	387	70	1.35	$180,591	$37,534
2018	266	475	68	1.66	$196,382	$41,710
2017	258	478	69	1.41	$195,829	$41,025
2016	258	474	68	1.42	$200,317	$39,410
2015	271	451	70	1.48	$190,175	$36,557
2014	199	371	70	1.25	$150,126	$28,562
2013	158	304	70	1.29	$125,824	$25,348

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 6 services

Sort by

Original Medicare services billed in 2023

New patient visit (45+ min)	92	$9,722	$106
Insertion of multicomponent inflatable penile implant	11	$7,947	$722
Short return visit (20+ min)	65	$5,210	$52
Return visit (30+ min)	60	$4,705	$76
Placement of hormone pellet under skin	19	$2,187	$45
Long return visit (40+ min)	18	$2,128	$118

2022: 5 services

Sort by

Original Medicare services billed in 2022

New patient visit (45+ min)	74	$7,910	$107
Short return visit (20+ min)	79	$5,514	$52
Return visit (30+ min)	54	$4,586	$82
Long return visit (40+ min)	18	$2,255	$125
Placement of hormone pellet under skin	15	$1,621	$42

2021: 7 services

Sort by

Original Medicare services billed in 2021

New patient visit (45+ min)	55	$5,468	$99
Short return visit (20+ min)	71	$4,961	$52
Long return visit (40+ min)	29	$3,843	$133
Return visit (30+ min)	46	$3,789	$81
Placement of hormone pellet under skin	13	$1,280	$43
Injection procedure to cause erection	11	$505	$39
Ultrasound of penis artery and vein blood flow	14	$236	$17

2020: 6 services

Sort by

Original Medicare services billed in 2020

New patient visit (45+ min)	58	$5,721	$99
Return visit (30+ min)	50	$3,302	$64
Short return visit (20+ min)	49	$3,033	$43
Long return visit (40+ min)	30	$2,735	$91
Placement of hormone pellet under skin	14	$930	$40
Injection procedure to cause erection	13	$841	$49

2019: 7 services

Sort by

Original Medicare services billed in 2019

New patient visit (45+ min)	64	$6,673	$104
Return visit (30+ min)	77	$4,928	$60
Short return visit (20+ min)	67	$3,778	$41
Long return visit (40+ min)	23	$2,168	$94
Placement of hormone pellet under skin	14	$1,496	$44
Diagnostic exam of bladder and urethra using an endoscope	12	$817	$68
Injection procedure to cause erection	15	$779	$52

2018: 7 services

Sort by

Original Medicare services billed in 2018

New patient visit (45+ min)	82	$8,381	$102
Short return visit (20+ min)	78	$4,955	$42
Return visit (30+ min)	65	$4,301	$59
Placement of hormone pellet under skin	15	$1,608	$42
New patient visit (30+ min)	19	$1,291	$68
Injection procedure to cause erection	18	$1,122	$49
Diagnostic exam of bladder and urethra using an endoscope	12	$805	$62

2017: 8 services

Sort by

Original Medicare services billed in 2017

New patient visit (45+ min)	84	$8,808	$105
Return visit (30+ min)	72	$4,656	$60
Short return visit (20+ min)	76	$4,434	$42
Placement of hormone pellet under skin	19	$1,664	$45
Long return visit (40+ min)	14	$1,038	$74
Injection procedure to cause erection	12	$989	$35
New patient visit (30+ min)	16	$950	$59
Electronic assessment of bladder emptying	13	$76	$6

2016: 8 services

Sort by

Original Medicare services billed in 2016

New patient visit (45+ min)	70	$7,167	$102
Return visit (30+ min)	74	$5,472	$61
Short return visit (20+ min)	100	$5,328	$40
Diagnostic exam of bladder and urethra using an endoscope	16	$2,061	$115
New patient visit (30+ min)	20	$1,153	$58
Placement of hormone pellet under skin	14	$895	$43
Injection procedure to cause erection	14	$881	$40
Electronic assessment of bladder emptying	20	$137	$7

2015: 7 services

Sort by

Original Medicare services billed in 2015

New patient visit (45+ min)	65	$7,078	$109
Return visit (30+ min)	71	$4,946	$64
Short return visit (20+ min)	87	$4,900	$44
New patient visit (30+ min)	45	$2,772	$62
Diagnostic exam of bladder and urethra using an endoscope	21	$2,609	$109
Injection procedure to cause erection	15	$918	$57
Electronic assessment of bladder emptying	20	$140	$7

2014: 7 services

Sort by

Original Medicare services billed in 2014

Return visit (30+ min)	90	$6,718	$61
New patient visit (45+ min)	40	$4,201	$105
Short return visit (20+ min)	64	$3,865	$43
Diagnostic exam of bladder and urethra using an endoscope	25	$2,728	$109
New patient visit (30+ min)	28	$1,823	$65
Injection procedure to cause erection	11	$726	$61
Electronic assessment of bladder emptying	14	$79	$6

2013: 7 services

Sort by

Original Medicare services billed in 2013

Return visit (30+ min)	100	$8,493	$61
New patient visit (45+ min)	33	$3,424	$104
Diagnostic exam of bladder and urethra using an endoscope	13	$1,545	$110
Short return visit (20+ min)	29	$1,229	$38
New patient visit (30+ min)	15	$927	$62
Injection procedure to cause erection	15	$920	$61
Electronic assessment of bladder emptying	18	$113	$6

Medicaid work

$1,524 in 2024

Medicaid paid $1,524 for 12 billed services this clinician did in 2024, up to 12 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2024

New patient visit (45+ min)	12	$1,524

Sort by

Medicaid work by year

2024	12	1	12	$1,524
2022	13	1	13	$1,033
2021	13	1	13	$1,482

See the largest Medicaid services in earlier years

2022

Sort by

Largest Medicaid services in 2022

New patient visit (45+ min)	13	$1,033

2021

Sort by

Largest Medicaid services in 2021

New patient visit (45+ min)	13	$1,482

Drugs they prescribed that Part D paid

$13,040

Pharmacies billed $13,040 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

100 generic and fewer than 11 brand-name prescriptions · $13,040 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Testosterone	13	$4,187	$322
Pentoxifylline	14	$325	$23
Tamsulosin	27	$312	$12

Year by year

Sort by

Part D prescribing by year

2024	105	43	None	None	$13,040
2023	136	47	None	None	$8,633
2022	157	51	None	None	$16,365
2021	214	69	None	8%	$29,311
2020	277	87	None	8%	$33,763
2019	235	58	None	None	$41,173
2018	265	77	None	None	$73,537
2017	279	76	None	27%	$62,761
2016	277	64	None	19%	$44,646
2015	298	76	None	None	$30,456
2014	184	51	None	15%	$15,722
2013	171	42	None	None	$8,437

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 4 drugs

Sort by

Part D drugs prescribed in 2023

Testosterone	18	$5,495	$305
Tamsulosin	37	$770	$21
Pentoxifylline	15	$575	$38
Finasteride	20	$526	$26

2022: 5 drugs

Sort by

Part D drugs prescribed in 2022

Testosterone	24	$6,376	$266
Pentoxifylline	15	$1,073	$72
Tamsulosin	31	$300	$10
Finasteride	17	$144	$8
Sildenafil Citrate	19	$95	$5

2021: 6 drugs

Sort by

Part D drugs prescribed in 2021

Testosterone	42	$12,541	$299
Cabergoline	15	$3,045	$203
Pentoxifylline	38	$1,637	$43
Testosterone Cypionate	12	$1,034	$86
Tamsulosin	48	$572	$12
Finasteride	20	$273	$14

2020: 6 drugs

Sort by

Part D drugs prescribed in 2020

Testosterone	68	$19,628	$289
Testosterone Cypionate	34	$2,483	$73
Pentoxifylline	44	$2,136	$49
Cabergoline	16	$2,039	$127
Tamsulosin	47	$600	$13
Finasteride	30	$514	$17

2019: 5 drugs

Sort by

Part D drugs prescribed in 2019

Testosterone	42	$20,211	$481
Testosterone Cypionate	29	$1,582	$55
Pentoxifylline	43	$1,143	$27
Tamsulosin	30	$406	$14
Finasteride	44	$358	$8

2018: 9 drugs

Sort by

Part D drugs prescribed in 2018

Androgel	27	$45,917	$1,701
Testosterone	17	$10,531	$619
Cialis	16	$5,423	$339
Vesicare	13	$4,715	$363
Testosterone Cypionate	35	$1,213	$35
Tamsulosin	35	$694	$20
Finasteride	43	$480	$11
Pentoxifylline	20	$368	$18
Sulfamethoxazole-Trimethoprim	12	$57	$5

2017: 8 drugs

Sort by

Part D drugs prescribed in 2017

Androgel	35	$45,074	$1,288
Cialis	13	$4,010	$308
Vesicare	12	$3,896	$325
Testosterone Cypionate	44	$1,731	$39
Tamsulosin	55	$1,355	$25
Finasteride	31	$473	$15
Pentoxifylline	29	$373	$13
Alfuzosin Hcl Er	11	$151	$14

2016: 5 drugs

Sort by

Part D drugs prescribed in 2016

Androgel	37	$31,971	$864
Tamsulosin	72	$3,586	$50
Testosterone Cypionate	32	$1,332	$42
Finasteride	34	$650	$19
Pentoxifylline	35	$466	$13

2015: 5 drugs

Sort by

Part D drugs prescribed in 2015

Androgel	24	$13,043	$543
Tamsulosin	75	$2,400	$32
Finasteride	74	$1,059	$14
Testosterone Cypionate	26	$786	$30
Pentoxifylline	17	$356	$21

2014: 3 drugs

Sort by

Part D drugs prescribed in 2014

Androgel	19	$9,887	$520
Tamsulosin	45	$718	$16
Finasteride	47	$575	$12

2013: 3 drugs

Sort by

Part D drugs prescribed in 2013

Finasteride	38	$1,038	$27
Tamsulosin	51	$918	$18
Alfuzosin	12	$224	$19

Money from drug and device companies

$467 in 2025

Sort by

Industry payments by year

2025	2	4	None	$467
2024	4	4	$600	$818
2023	5	8	None	$487
2021	1	2	$4,675	$4,675
2020	1	3	$20,400	$20,400
2019	1	3	$7,931	$7,931

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Sort by

Payments by company

Coloplast	Titan	$450	3 payments Meals for Titan · 2025-10-10 · $171 Meals for Genesis · 2025-04-26 · $133 Meals for Titan · 2025-02-26 · $145
Ambu	None	$18	1 payment Meals · 2025-01-27 · $18

See all 4 published payments

Sort by

Every published payment

Coloplast	Meals · 2025-10-10	Titan	$171
Coloplast	Meals · 2025-04-26	Genesis	$133
Coloplast	Meals · 2025-02-26	Titan	$145
Ambu	Meals · 2025-01-27	None	$18

See earlier years (2024, 2023, 2021, 2020, 2019)

2024: $818

Sort by

Payments by company in 2024

Boston Scientific	Ams 700	$600	1 payment Paid to speak or teach for Ams 700 · 2024-07-05 · $600
Coloplast	Titan	$151	1 payment Meals for Titan · 2024-10-18 · $151
Endo USA	Xiaflex	$51	1 payment Meals for Xiaflex · 2024-10-18 · $51
EMD Serono	None	$16	1 payment Meals · 2024-10-20 · $16

2023: $487

Sort by

Payments by company in 2023

Coloplast	Titan	$350	4 payments Travel for Titan · 2023-11-19 · $10 Meals for Titan · 2023-11-18 · $153 Meals for Titan · 2023-10-26 · $16 Meals for Titan · 2023-04-28 · $172
Antares Pharma	Tlando	$50	1 payment Meals for Tlando · 2023-04-28 · $50
Boston Scientific	None	$41	1 payment Meals · 2023-11-18 · $41
Axonics	Axonics	$25	1 payment Meals for Axonics · 2023-05-02 · $25
EMD Serono	None	$21	1 payment Meals · 2023-10-16 · $21

2021: $4,675

Sort by

Payments by company in 2021

Gilead Sciences	None	$4,675	2 payments Consulting · 2021-09-13 · $1,275 Consulting · 2021-03-24 · $3,400

2020: $20,400

Sort by

Payments by company in 2020

Gilead Sciences	None	$20,400	3 payments Consulting · 2020-07-27 · $10,625 Consulting · 2020-04-01 · $5,100 Consulting · 2020-01-13 · $4,675

2019: $7,931

Sort by

Payments by company in 2019

Gilead Sciences	None	$7,931	3 payments Consulting · 2019-10-30 · $1,981 Consulting · 2019-07-22 · $1,913 Consulting · 2019-05-20 · $4,038

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score: 76.5 / 100; Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI: 1508999749
Licence: CA A93272California A93272: Current · expires 2027-07-31
Trained: Yale University School of Medicine, 2004
Group: Stanford Health Care
Video visits: Lists video visits
Gender: Male

More record details

Sole proprietor: Yes
Taxonomy: Urology (208800000X); Surgery (208600000X)
Mailing address: 300 Pasteur Drive, Stanford, CA, 94305
NPI first listed: 2007-03-14
NPI last updated: 2024-03-13
NPI record certified: 2024-03-13

This is when the NPI record was last certified, not a medical board exam.